Literature DB >> 24737546

Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind.

Aminat O Oluyemi1, Amy R Welch, Lisa J Yoo, Erik B Lehman, Thomas J McGarrity, Cynthia H Chuang.   

Abstract

BACKGROUND: There is limited information about colorectal cancer (CRC) screening trends in high-risk groups, including the black, obese, diabetic, and smoking populations. For this study, the authors evaluated national CRC screening trends in these high-risk groups to provide insights into whether screening resources are being appropriately used.
METHODS: This was a nationally representative, population-based study using the Behavioral Risk Factor Surveillance System from the Centers for Disease Control. Data analysis was performed using bivariate analyses with weighted logistic regression.
RESULTS: In the general population, CRC screening increased significantly from 59% to 65% during the years 2006 to 2010. The screening prevalence in non-Hispanic blacks was 58% in 2006 and 65% in 2010. Among obese individuals, the prevalence of up-to-date CRC screening increased significantly from 59% in 2006 to 66% in 2010. Screening prevalence in individuals with diabetes was 63% in 2006 and 69% in 2010. The CRC screening prevalence in current smokers was 45% in 2006 and 50% in 2010. The odds of CRC screening in the non-Hispanic black population, the obese population, and the diabetic population were higher than in non-Hispanic whites, normal weight individuals, and the population without diabetes, respectively. Current smokers had significantly lower odds of CRC screening than never-smokers in the years studied (2006: odds ratio [OR], 0.71; 95% confidence interval [CI], 0.66-0.76; 2008: OR, 0.67; 95% CI, 0.63-0.71; 2010: OR, 0.69; 95% CI, 0.66-0.73).
CONCLUSIONS: The prevalence of CRC screening in high-risk groups is trending upward. Despite this, current smokers have significantly lower odds of CRC screening compared with the general population.
© 2014 American Cancer Society.

Entities:  

Keywords:  colorectal cancer; colorectal cancer screening; current smokers; high-risk groups

Mesh:

Year:  2014        PMID: 24737546     DOI: 10.1002/cncr.28707

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Do recent epidemiologic observations impact who and how we should screen for CRC?

Authors:  Ethan Bortniker; Joseph C Anderson
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

2.  Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial.

Authors:  Caitlin C Murphy; Sally W Vernon; Nicole M Haddock; Melissa L Anderson; Jessica Chubak; Beverly B Green
Journal:  Prev Med       Date:  2014-06-15       Impact factor: 4.018

Review 3.  Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis.

Authors:  Dominika Bhatia; Iliana C Lega; Wei Wu; Lorraine L Lipscombe
Journal:  Diabetologia       Date:  2019-10-24       Impact factor: 10.122

Review 4.  Targeting regulation of tryptophan metabolism for colorectal cancer therapy: a systematic review.

Authors:  Hong-Lian Zhang; Ai-Hua Zhang; Jian-Hua Miao; Hui Sun; Guang-Li Yan; Fang-Fang Wu; Xi-Jun Wang
Journal:  RSC Adv       Date:  2019-01-23       Impact factor: 4.036

5.  Synergistic Effects of Genetic Variants of Glucose Homeostasis and Lifelong Exposures to Cigarette Smoking, Female Hormones, and Dietary Fat Intake on Primary Colorectal Cancer Development in African and Hispanic/Latino American Women.

Authors:  Su Yon Jung; Eric M Sobel; Matteo Pellegrini; Herbert Yu; Jeanette C Papp
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

6.  Genetic Signatures of Glucose Homeostasis: Synergistic Interplay With Long-Term Exposure to Cigarette Smoking in Development of Primary Colorectal Cancer Among African American Women.

Authors:  Su Yon Jung
Journal:  Clin Transl Gastroenterol       Date:  2021-10-05       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.